- AppliedVR announced a collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) to evaluate virtual reality (VR) as a solution to help address the underlying cancer-related anxiety. - The proof-of-concept study will evaluate AppliedVR’s virtual reality system on neuro-oncology patients’ “scanxiety,” a term used to describe the anxiety patients with cancer experience before or after medical diagnostics scans.AppliedVR, a Los Angeles, CA-based
Read More
AppliedVR Awarded $2.9M Grants to Study Virtual Reality As An Opioid-Sparing Treatment
- AppliedVR awarded more than $2.9M in NIDA grants to support clinical trials to study virtual reality platforms as an opioid-sparing tool for acute and chronic pain. - The grants will enable the company to advance two clinical trial programs respectively with Geisinger and Cleveland Clinic.AppliedVR, a Los Angeles, CA-based next generation of digital medicine announced that it has been awarded two multi-year grants totaling more than $2.9 million from the National Institute on Drug Abuse
Read More
Ochsner Accountable Care Network Saves $12.9M for Medicare Beneficiaries
- The Ochsner Accountable Care Network reduces the cost of care by $12.87M for over 24,000 Medicare beneficiaries, representing 81% increase in savings per beneficiary and a 12% increase in total savings in 2018. - Development of Outpatient Complex Case Management and MedVantage Clinics was one of the efforts that contributed to the savings.The Ochsner Accountable Care Network, LLC (OACN) is pleased to report its 2018 savings results, which include a reduction in the expected cost of care by
Read More
Lafayette General Health Signs Intent to Merge with Ochsner Health System: 7 Things to Know
- The Board of Trustees of Lafayette General Health and Ochsner Health System have signed a letter of intent for Lafayette General to merge with Ochsner Health System.
- Ochsner will invest $365 million in capital and resources in Acadiana over the next 10 years.
- A 10-year, $10 million Community Support Fund overseen by the Lafayette General Board will be created to advance health and wellness in Acadiana.
- $1 million will be invested in the Healthcare Innovation Fund at
Read More
Backed by Optum Ventures, Kaia Health Raises $8M for AI-Driven Digital Therapeutics for Back Pain & COPD
- Digital therapeutics startup Kaia Health raises $8M in funding led by Optum Ventures to support the accelerated execution of clinical trials required to demonstrate efficacy to the FDA.- Kaia Health utilizes multimodal therapy, which combines physical, psychological and educational elements to relieve back pain at home, without medication.- Optum’s investment in Kaia Health will consider use of Kaia Health’s digital therapeutic offerings for back pain and COPD with Optum and UnitedHealth
Read More
TrialCard Acquires Digital Medication & Adherence Platform Mango Health
- TrialCard acquires digital medication management platform Mango Health to offer a best-in-class engagement and adherence solution to patients.
- The announcement marks the third acquisition for TrialCard in the past year.
- TrialCard Incorporated provides patient affordability, medication access and adherence, and patient support connecting over 30 million patients with nearly $12B in branded drug savings to date.
TrialCard
Incorporated announced it has entered an agreement to
Read More
Cognoa, EVERSANA Partner to Advance the Commercialization Standard for Prescription Digital Medicines
- Cognoa and EVERSANA form a partnership that will enable prescription, dispensation, and reimbursement of Cognoa’s behavioral health products.
- Cognoa is developing digital medicine solutions to change the standard of care in pediatric behavioral health to improve the lifelong outcomes for children.
- Cognoa selected EVERSANA, a fully integrated and independent commercial services platform, to develop and manage a go-to-market strategy that ensures comprehensive market
Read More
Cleveland Clinic Study: Propeller Health’s Smart Inhalers Reduces Hospitalizations, ER Visits for COPD Patients
Cleveland Clinic today released research that uses Propeller Health’s smart inhaler platform to show that digital medicines significantly reduced hospital visits for COPD patients. COPD is a term applied to a family of diseases that includes emphysema, chronic bronchitis, and emphysema due to alpha-1 antitrypsin deficiency. The research findings published in The Journal of Telemedicine and Telecare marks the first-ever research to assess the impact of a digital medicine on healthcare utilization
Read More
UCSF, The Doctors Company Partner to Address Patient Safety Challenges in the Digital Health Era
The Doctors Company—the nation’s largest physician-owned medical malpractice insurer—and UC San Francisco (UCSF), today launched a new partnership at the intersection of digital medicine and patient safety. The Doctors Company’s commitment to advancing the practice of good medicine will be expanded through a $1 million collaboration that will enable leading UCSF researchers in evidence-based patient safety practices, safety, and information technology–related policy, and artificial intelligence
Read More
Consumer Awareness of Personalized Medicine Has Only Grown by 1% YoY Since 2013
Consumer awareness of personalized medicine is up 4% from 2018, according to a new report from Dosis, an AI-powered personalized dosing platform. The 2019 Dosis Personalized and Digital Medicine Consumer Report surveyed more than 1,000 consumers, weighted for the U.S. population, to gain a better understanding of how big the disconnect is between the advances in personalized medicine approaches and general consumer awareness of its benefits.Consumer Awareness of Personalized Medicine Continues
Read More